Clinical Trials Browser

Phase 1 × Solid Tumor, Adult × pembrolizumab × Clear all

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

First In Human Study of CX-801 in Advanced Solid Tumors